申请人:ELI LILLY AND COMPANY
公开号:EP0584952A1
公开(公告)日:1994-03-02
The current invention provides compounds, methods and pharmaceutical formulations for use in treating or preventing osteoporosis by inhibiting the loss of bone. These compounds, methods and formulations can be used without the associated adverse effects of estrogen therapy, and thus are effective in the prevention or treatment of osteoporosis.
本发明提供了用于通过抑制骨质流失来治疗或预防骨质疏松症的化合物、方法和药物制剂。使用这些化合物、方法和制剂不会产生雌激素疗法的相关不良反应,因此可有效预防或治疗骨质疏松症。